Alzheimer disease (AD) is the most common form of neurodegenerative disease, estimated
to contribute 60–70% of all cases of dementia worldwide. According to the prevailing …

Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on
the lives and health of people around the globe. As of 4 July 2021, more than 183 million …

Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid
strategies with disappointing results. It is clear that the “amyloid cascade hypothesis” alone …

Alzheimer’s disease is characterized by the histopathological presence of amyloid-β
plaques and tau-containing neurofibrillary tangles. Microglial activation is also a recognized …

Compelling experimental evidence suggests that microglial activation is involved in the spread
of tau tangles over the neocortex in Alzheimer’s disease (AD). We tested the hypothesis …

[11C](R)PK11195-PET is a marker of activated microglia while [11C]PIB-PET detects raised
amyloid load. Here we studied in vivo the distributions of amyloid load and microglial …

Background: Neuropathological studies have reported varying amounts of amyloid
pathology in dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). [11C]PIB …

Amyloid-β deposition, neuroinflammation and tau tangle formation all play a significant role
in Alzheimer’s disease. We hypothesized that there is microglial activation early on in …

PET with [ 11 C]-(R)-PK11195 is currently the modality of choice for the in vivo imaging of
microglial activation in the human brain. In this work we devised a supervised clustering …

There is widespread evidence both of the exclusion of older people from clinical research,
and of under-recruitment to clinical trials. This review and opinion piece provides practical …